Brookstone Capital Management Lowers Stock Holdings in HCA Healthcare, Inc. $HCA

Brookstone Capital Management decreased its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 6.6% during the second quarter, Holdings Channel reports. The institutional investor owned 3,471 shares of the company’s stock after selling 245 shares during the period. Brookstone Capital Management’s holdings in HCA Healthcare were worth $1,330,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Cheviot Value Management LLC purchased a new stake in HCA Healthcare in the 1st quarter worth $26,000. Saudi Central Bank purchased a new stake in HCA Healthcare in the 1st quarter worth $26,000. WPG Advisers LLC purchased a new stake in HCA Healthcare in the 1st quarter worth $27,000. Ameriflex Group Inc. purchased a new stake in HCA Healthcare in the 2nd quarter worth $27,000. Finally, Chung Wu Investment Group LLC purchased a new stake in HCA Healthcare in the 2nd quarter worth $27,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of the company’s stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. This represents a 10.85% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.30% of the company’s stock.

Analysts Set New Price Targets

HCA has been the topic of a number of research reports. Royal Bank Of Canada reduced their target price on shares of HCA Healthcare from $404.00 to $401.00 and set an “outperform” rating on the stock in a report on Monday, July 28th. Mizuho boosted their target price on shares of HCA Healthcare from $425.00 to $475.00 and gave the stock an “outperform” rating in a report on Friday, October 17th. Cantor Fitzgerald restated an “overweight” rating and issued a $444.00 target price on shares of HCA Healthcare in a report on Tuesday, October 7th. Wolfe Research downgraded shares of HCA Healthcare from an “outperform” rating to a “peer perform” rating in a report on Monday, July 28th. Finally, Weiss Ratings reiterated a “buy (b-)” rating on shares of HCA Healthcare in a report on Saturday. One equities research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average price target of $437.19.

HCA Healthcare Price Performance

Shares of HCA stock opened at $446.58 on Friday. The company has a market capitalization of $104.50 billion, a P/E ratio of 17.26, a P/E/G ratio of 1.41 and a beta of 1.40. The company’s 50-day simple moving average is $414.84 and its two-hundred day simple moving average is $382.03. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $461.56.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. The business had revenue of $19.16 billion for the quarter, compared to the consensus estimate of $18.55 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be paid a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare’s dividend payout ratio is currently 12.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.